Decreased nitric oxide content mediated by asymmetrical dimethylarginine and proteinl -arginine methyltransferase 3 in macrophages induces trophoblast apoptosis: a potential cause of recurrent miscarriage
| Autor: | Fan Hao, Yongbo Zhao, Liping Jin, Xiang-Hong Xu, Lin-Chen Tang, Wen-Xuan Li, Jia-Xue Sun |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
Abortion Habitual China Protein-Arginine N-Methyltransferases Stromal cell Arginine Apoptosis Nitric Oxide Nitric oxide Andrology Mice chemistry.chemical_compound Pregnancy Decidua Animals Humans Medicine Fetus biology business.industry Macrophages Rehabilitation Intracellular Signaling Peptides and Proteins Obstetrics and Gynecology Trophoblast Trophoblasts Nitric oxide synthase medicine.anatomical_structure Reproductive Medicine chemistry Mice Inbred DBA Mice Inbred CBA biology.protein Female business |
| Zdroj: | Human Reproduction. 36:3049-3061 |
| ISSN: | 1460-2350 0268-1161 8173-0039 |
| DOI: | 10.1093/humrep/deab225 |
| Popis: | STUDY QUESTIONIs the protein l-arginine methyltransferase 3 (PRMT3)/asymmetrical dimethylarginine (ADMA)/nitric oxide (NO) pathway involved in the development of recurrent miscarriage (RM), and what is the potential mechanism?SUMMARY ANSWERElevated levels of PRMT3 and ADMA inhibit NO formation in the decidua, thereby impairing the functions of trophoblast cells at the maternal–foetal interface.WHAT IS KNOWN ALREADYDecreased NO bioavailability is associated with RM. ADMA, an endogenous inhibitor of nitric oxide synthase (NOS), is derived from the methylation of protein arginine residues by PRMTs and serves as a predictor of mortality in critical illness.STUDY DESIGN, SIZE, DURATIONA total of 145 women with RM and 149 healthy women undergoing elective termination of an early normal pregnancy were enrolled. Ninety-six female CBA/J, 24 male DBA/2 and 24 male BALB/c mice were included. CBA/J × DBA/2 matings represent the abortion group, while CBA/J × BALB/c matings represent the normal control group. The CBA/J pregnant mice were then categorised into four groups: (i) normal + vehicle group (n = 28), (ii) abortion + vehicle group (n = 28), (iii) normal + SGC707 (a PRMT3 inhibitor) group (n = 20) and (iv) abortion + SGC707 group (n = 20). All injections were made intraperitoneally on Days 0.5, 3.5 and 6.5 of pregnancy. Decidual tissues were collected on Days 8.5, 9.5 and 10.5 of gestation. The embryo resorption rates were calculated on Day 9.5 and Day 10.5 of gestation.PARTICIPANTS/MATERIALS, SETTING, METHODSNO concentration, ADMA content, NOS activity, expression levels of NOS and PRMTs in decidual tissues were determined using conventional assay kits or western blotting. PRMT3 expression was further analysed in decidual stromal cells, macrophages and natural killer cells. A co-culture system between decidual macrophages (DMs) and HTR-8/SVneo trophoblasts was constructed to study the roles of the PRMT3/ADMA/NO signalling pathway. Trophoblast apoptosis was analysed via Annexin V-fluorescein isothiocyanate/propidium iodide staining. CBA/J × DBA/2 mouse models were used to investigate the effects of SGC707 on embryo resorption rates.MAIN RESULTS AND THE ROLE OF CHANCEOur results show that NO concentration and NOS activity were decreased, but ADMA content and PRMT3 expression were increased in the decidua of RM patients. Moreover, compared with the normal control subjects, PRMT3 expression was significantly up-regulated in the macrophages but not in the natural killer cells or stromal cells of the decidua from RM patients. The inhibition of PRMT3 results in a significant decrease in ADMA accumulation and an increase in NO concentration in macrophages. When co-cultured with DMs, which were treated with SGC707 and ADMA, trophoblast apoptosis was suppressed and induced, respectively. In vivo experiments revealed that the administration of SGC707 reduced the embryo resorption rate of CBA/J × DBA/2 mice.LIMITATIONS, REASONS FOR CAUTIONAll sets of experiments were not performed with the same samples. The main reason is that each tissue needs to be reserved for clinical diagnosis and only a small piece of each tissue can be cut and collected for this study.WIDER IMPLICATIONS OF THE FINDINGSOur results indicate that the PRMT3/ADMA/NO pathway is a potential marker and target for the clinical diagnosis and therapy of RM.STUDY FUNDING/COMPETING INTEREST(S)This study was supported by the National Key Research and Development Program of China (2017YFC1001401), National Natural Science Foundation of China (81730039, 82071653, 81671460, 81971384 and 82171657) and Shanghai Municipal Medical and Health Discipline Construction Projects (2017ZZ02015). The authors have declared no conflict of interest.TRIAL REGISTRATION NUMBERN/A. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|